TickerFacts.

Volitionrx Ltd (VNRX): Net Income

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2024-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$23.36M
Year ended 2025-12-31
-$25.64M
Trailing 12 months to 2026-06-30
2011-12-31: -$2.61M2012-12-31: -$4.08M2013-12-31: -$3.71M2014-12-31: -$8.21M2015-12-31: -$9.53M2016-12-31: -$11.91M2017-12-31: -$14.77M2018-12-31: -$18.01M2019-12-31: -$16.10M2020-12-31: -$20.40M2021-12-31: -$26.99M2022-12-31: -$30.60M2023-12-31: -$35.68M2024-12-31: -$26.97M2025-12-31: -$23.36M-$23.36M
2011-12-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31-$23.36Mn/m2026-03-31, From 2025-01-01
2024-12-31-$26.97Mn/c2026-03-31, From 2024-01-01
2023-12-31-$35.68Mn/m2025-03-31, From 2023-01-01
2022-12-31-$30.60Mn/m2024-03-25, From 2022-01-01
2021-12-31-$26.99Mn/m2023-03-15, From 2021-01-01
2020-12-31-$20.40Mn/m2022-03-30, From 2020-01-01
2019-12-31-$16.10Mn/m2021-03-22, From 2019-01-01
2018-12-31-$18.01Mn/m2020-02-20, From 2018-01-01
2017-12-31-$14.77Mn/m2019-03-13, From 2017-01-01
2016-12-31-$11.91Mn/m2018-03-01, From 2016-01-01
2015-12-31-$9.53Mn/m2017-03-10, From 2015-01-01
2014-12-31-$8.21Mn/m2016-03-11, From 2014-01-01
2013-12-31-$3.71Mn/m2015-03-18, From 2013-01-01
2012-12-31-$4.08Mn/m2014-03-28, From 2012-01-01
2011-12-31-$2.61Mn/a2013-04-01, From 2011-01-01

Net Income at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
Volitionrx Ltd (VNRX)2025-12-31-$23.36Mn/m
Celldex Therapeutics, Inc. (CLDX)2025-12-31-$258.76Mn/m
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31-$50.22Mn/m
Biomerica Inc (BMRA)2026-05-31-$3.77Mn/m
Anbio Biotechnology (NNNN)2025-12-31$6.40M+169.9%
Aspira Women's Health Inc. (AWHL)2025-12-31-$12.78Mn/m
Immucell Corp (ICCC)2025-12-31-$1.04Mn/m
Alpha Teknova, Inc. (TKNO)2025-12-31-$17.26Mn/m
Intellia Therapeutics, Inc. (NTLA)2025-12-31-$412.69Mn/m

Compare VNRX, CLDX, IMDX, BMRA side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗